Scoping review identifies factors associated with the onset of infant acute lymphoblastic leukaemia January 31, 2025 Scoping review identifies factors associated with the onset of infant acute lymphoblastic leukaemia
The Josep Carreras Research Institute and Cytognos S.L. develop a kit to determine the prognosis of patients diagnosed with Acute Myeloid Leukaemia March 03, 2021 The Josep Carreras Research Institute and Cytognos S.L. develop a kit to determine the prognosis of patients diagnosed with Acute Myeloid Leukaemia
The Josep Carreras Leukaemia Research Institute, new Member Institution at the International Cancer Proteogenome Consortium of the National Cancer Institute February 25, 2021 The Josep Carreras Leukaemia Research Institute, new Member Institution at the International Cancer Proteogenome Consortium of the National Cancer Institute
Myelodysplastic Syndrome heterogeneity revealed using single cell technology February 23, 2021 Myelodysplastic Syndrome heterogeneity revealed using single cell technology
The Josep Carreras Institute organizes the Symposium "The Immune System: in sickness and in health" February 19, 2021 The Josep Carreras Institute organizes the Symposium "The Immune System: in sickness and in health"
Adding genomics criteria to the classification of Myelodysplastic Syndromes improves its prognosis February 19, 2021 Adding genomics criteria to the classification of Myelodysplastic Syndromes improves its prognosis
The Josep Carreras Institute opens a new Cell Immortalization Unit February 12, 2021 The Josep Carreras Institute opens a new Cell Immortalization Unit
Researchers from Josep Carreras Institute participate in the program 100tífiques aimed at fostering science careers among school girls February 11, 2021 Researchers from Josep Carreras Institute participate in the program 100tífiques aimed at fostering science careers among school girls
An international team measures the importance of the genetic background in cancer immunotherapy February 10, 2021 An international team measures the importance of the genetic background in cancer immunotherapy
The Josep Carreras Leukaemia Research Institute opens a new lab devoted to Endothelial Pathobiology and Microenviroment February 08, 2021 The Josep Carreras Leukaemia Research Institute opens a new lab devoted to Endothelial Pathobiology and Microenviroment
Anna Bigas, new Deputy Director of Preclinical Research at the Josep Carreras Leukemia Research Institute February 05, 2021 Anna Bigas, new Deputy Director of Preclinical Research at the Josep Carreras Leukemia Research Institute
